Evidence map›Paper›PMID 38647279›Full record

ArticleActa physiologica (Oxford, England)2024

Smoking cessation only partially reverses cardiac metabolic and structural remodeling in mice.

Jekaterina Aid, Ajime Tom Tanjeko, Jef Serré, Moritz Eggelbusch, Wendy Noort, Gerard M J de Wit, Michel van Weeghel, Marju Puurand, Kersti Tepp, Ghislaine Gayan-Ramirez and 3 more

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Acta physiologica (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Lasting consequences of cigarette smoking on the heart.Acta physiologica (Oxford, England) · 2024
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Jekaterina AidLaboratory of Chemical Biology, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.ORCID 0000-0003-4533-7179
Ajime Tom TanjekoLaboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases, and Metabolism, KU-Leuven, Leuven, Belgium.ORCID 0000-0002-8779-8929
Jef SerréLaboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases, and Metabolism, KU-Leuven, Leuven, Belgium.ORCID 0000-0002-9562-3416
Moritz EggelbuschLaboratory of Myology, Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-4006-4063
Wendy NoortLaboratory of Myology, Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-3578-7611
Gerard M J de WitLaboratory of Myology, Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Michel van WeeghelLaboratory Genetic Metabolic Diseases, Amsterdam UMC, Amsterdam Gastroenterology and Metabolism, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-4916-2866
Marju PuurandLaboratory of Chemical Biology, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.ORCID 0000-0002-0083-3390
Kersti TeppLaboratory of Chemical Biology, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.ORCID 0000-0001-7367-6632
Ghislaine Gayan-RamirezLaboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases, and Metabolism, KU-Leuven, Leuven, Belgium.ORCID 0000-0001-9652-7437
Hans DegensDepartment of Life Sciences, Institute of Sport, Manchester Metropolitan University, Manchester, UK.ORCID 0000-0001-7399-4841
Tuuli KäämbreLaboratory of Chemical Biology, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.ORCID 0000-0001-5755-4694
Rob C I WüstLaboratory of Myology, Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-3781-5177
National Institute of Chemical Physics and Biophysics · EEVrije Universiteit Amsterdam · NLKU Leuven · BEManchester Metropolitan University · GBAmsterdam Neuroscience · NL

Funding

DoraPlusEuropean Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program (2011-2015)
6 · The paper itself

Abstract

aimsActive cigarette smoking is a major risk factor for chronic obstructive pulmonary disease that remains elevated after cessation. Skeletal muscle dysfunction has been well documented after smoking, but little is known about cardiac adaptations to cigarette smoking. The underlying cellular and molecular cardiac adaptations, independent of confounding lifestyle factors, and time course of reversibility by smoking cessation remain unclear. We hypothesized that smoking negatively affects cardiac metabolism and induces local inflammation in mice, which do not readily reverse upon 2-week smoking cessation.

methodsMice were exposed to air or cigarette smoke for 14 weeks with or without 1- or 2-week smoke cessation. We measured cardiac mitochondrial respiration by high-resolution respirometry, cardiac mitochondrial density, abundance of mitochondrial supercomplexes by electrophoresis, and capillarization, fibrosis, and macrophage infiltration by immunohistology, and performed cardiac metabolome and lipidome analysis by mass spectrometry.

resultsMitochondrial protein, supercomplex content, and respiration (all p < 0.03) were lower after smoking, which were largely reversed within 2-week smoking cessation. Metabolome and lipidome analyses revealed alterations in mitochondrial metabolism, a shift from fatty acid to glucose metabolism, which did not revert to control upon smoking cessation. Capillary density was not different after smoking but increased after smoking cessation (p = 0.02). Macrophage infiltration and fibrosis (p < 0.04) were higher after smoking but did not revert to control upon smoking cessation.

conclusionsWhile cigarette-impaired smoking-induced cardiac mitochondrial function was reversed by smoking cessation, the remaining fibrosis and macrophage infiltration may contribute to the increased risk of cardiovascular events after smoking cessation.

Indexed as

Smoking CessationAnimalsMaleMiceMice, Inbred C57BLMitochondria, HeartMyocardiumVentricular Remodelingcardiac metabolismcardiac remodelingfibrosisinflammationmacrophagessmoking cessation

Identifiers

PMID38647279
OpenAlexW4395011948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.